0001836562-23-000001.txt : 20230602
0001836562-23-000001.hdr.sgml : 20230602
20230602170250
ACCESSION NUMBER: 0001836562-23-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230602
DATE AS OF CHANGE: 20230602
EFFECTIVENESS DATE: 20230602
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hopewell Therapeutics, Inc.
CENTRAL INDEX KEY: 0001836562
IRS NUMBER: 823045662
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-483254
FILM NUMBER: 23989961
BUSINESS ADDRESS:
STREET 1: 405 WALTHAM STREET
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617 921 7082
MAIL ADDRESS:
STREET 1: 405 WALTHAM STREET
CITY: LEXINGTON
STATE: MA
ZIP: 02421
D
1
primary_doc.xml
X0708
D
LIVE
0001836562
Hopewell Therapeutics, Inc.
301 West Cummings Park
Woburn
MA
MASSACHUSETTS
01801
617 921 7082
DELAWARE
None
None
Corporation
true
2018
Thomas
Hennessey
c/o Hopewell Therapeutics, Inc.
310 West Cummings Park
Woburn
MA
MASSACHUSETTS
01801
Executive Officer
Director
Thomas
Hennessey
c/o Hopewell Therapeutics, Inc.
310 West Cummings Park
Woburn
MA
MASSACHUSETTS
01801
Director
Xutian
Jing
c/o Hopewell Therapeutics, Inc.
310 West Cummings Park
Woburn
MA
MASSACHUSETTS
01801
Director
Howard
Rosen
c/o Hopewell Therapeutics, Inc.
310 West Cummings Park
Woburn
MA
MASSACHUSETTS
01801
Director
Jake
Xia
c/o Hopewell Therapeutics, Inc.
310 West Cummings Park
Woburn
MA
MASSACHUSETTS
01801
Director
Qiaobing
Xu
c/o Hopewell Therapeutics, Inc.
310 West Cummings Park
Woburn
MA
MASSACHUSETTS
01801
Executive Officer
Director
Biotechnology
Decline to Disclose
- 06b
false
2023-05-19
false
true
false
0
10000001
3000002
6999999
false
1
0
0
0
false
Hopewell Therapeutics, Inc.
/s/ Louis Brenner
Louis Brenner
President and CEO
2023-06-02